title: Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands.
abstract: Routine vaccination with a single dose of conjugated meningococcal C vaccine at 14 months and a catch-up campaign have reduced the incidence of meningococcal C disease in the Netherlands. In contrast to countries where routine vaccination is given in infancy, vaccine failures were not reported. This suggests that one dose of conjugated vaccine in the second year of life might offer longer lasting protection against meningococcal C disease than 3 doses in infancy.
authors.affiliation: National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands. sabine.de.greeff@rivm.nl
authors.forename: Sabine C
authors.initials: SC
authors.lastname: de Greeff
authors.forename: Hester E
authors.initials: HE
authors.lastname: de Melker
authors.forename: Lodewijk
authors.initials: L
authors.lastname: Spanjaard
authors.forename: Leo M
authors.initials: LM
authors.lastname: Schouls
authors.forename: Arie
authors.initials: A
authors.lastname: van Derende
mesh_terms: D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D006801:Humans; D015994:Incidence; D007223:Infant; D008585:Meningitis, Meningococcal / Q000453:epidemiology* / Q000517:prevention & control*; D008589:Meningococcal Infections / Q000453:epidemiology* / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D009426:Netherlands / Q000453:epidemiology
chemical_list: D022401:Meningococcal Vaccines; C410218:serogroup C meningococcal conjugate vaccine